EMERALD ADVISERS, LLC Reata Pharmaceuticals, Inc. Transaction History

EMERALD ADVISERS, LLC portfolio value:

$13.52M
portfolio value

EMERALD ADVISERS, LLC quarter portfolio value change:

-17.31%
quarter

Reata Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +88.08% 252.07K shares 4.82M $25.13 538.25K
Q2 2022 share Increase +5.66% 15.33K shares -176K $30.39 286.18K
Q1 2022 share Increase +51.42% 91.97K shares 4.15M $32.76 270.84K
Q4 2021 share Decrease -35.23% -97.28K shares -23.06M $26.38 178.87K
Q3 2021 share Increase +12.06% 29.71K shares -7.09M $100.61 276.15K
Q2 2021 share Decrease -5.75% -15.02K shares 8.81M $141.53 246.44K
Q1 2021 share Increase 0.00% 261.46K shares 26.06M $99.7 261.46K
Q3 2020 share Decrease -100.00% -63.47K shares -9.90M $97.42 0
Q2 2020 share Decrease -44.58% -51.06K shares -6.62M $156.02 63.47K
Q1 2020 share Increase +12.17% 12.42K shares -4.34M $144.34 114.53K
Q4 2019 share Decrease -63.90% -180.70K shares -1.83M $204.43 102.10K
Q3 2019 share Decrease -26.99% -104.55K shares -13.84M $80.29 282.81K
Q2 2019 share Decrease -1.20% -4.72K shares 3.03M $94.35 387.36K
Q1 2019 share Decrease -16.65% -78.34K shares 7.12M $85.47 392.08K
Q4 2018 share Decrease -0.60% -2.84K shares -12.30M $56.1 470.43K
Q3 2018 share Decrease -13.24% -72.24K shares 19.61M $81.76 473.27K
Q2 2018 share Increase +10.48% 51.76K shares 8.95M $34.97 545.52K
Q1 2018 share Decrease -12.10% -67.98K shares -5.78M $20.51 493.75K
Q4 2017 share Decrease -1.35% -7.68K shares -1.80M $28.32 561.73K
Q3 2017 share Increase +40.10% 162.99K shares 4.85M $31.1 569.41K
Q2 2017 share Increase +9.79% 36.22K shares 4.47M $31.64 406.42K
Q1 2017 share Increase +13.16% 43.05K shares 1.24M $22.65 370.19K
Q4 2016 share Increase +35.81% 86.26K shares 792K $21.83 327.14K
Q3 2016 share Increase +43.71% 73.26K shares 3.04M $26.36 240.87K
Q2 2016 share Increase 0.00% 167.61K shares 3.31M $19.75 167.61K